C. Ferrero-Vacher

Evaluation of the ABX Cobas Vega automated hematology analyzer and comparison with the Coulter STKS.

J. Bayle, D. Jambou, D. Vanhaeke, 1997, Hematology and cell therapy.

Evaluation of the Sysmex Xe‐2100® hematology analyzer in hospital use

J. Bayle, C. Ferrero-Vacher, D. Nakul-Aquaronne, 2003, Journal of clinical laboratory analysis.

Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report

T. Cluzeau, T. Passeron, M. Loschi, 2022, Bone Marrow Transplantation.

A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome

H. Cavé, N. Sirvent, P. Boutté, 2005 .

[Chorea-acanthocytosis without acanthocytes].

M. Borg, A. Chaussenot, C. Lebrun, 2010, Revue neurologique.

Clinical and molecular variability in congenital dyserythropoietic anaemia type I

H. Tamary, I. Yaniv, B. Bader-Meunier, 2005, British journal of haematology.

[Neonatal Pearson syndrome. two case studies].

F. Monpoux, P. Boutté, C. Ferrero-Vacher, 2010, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Molecular Basis of Congenital Dyserythropoietic Anemia Type I in French Patients.

H. Tamary, I. Yaniv, B. Bader-Meunier, 2004 .

A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome.

H. Cavé, N. Sirvent, P. Boutté, 2005, Acta paediatrica.